Search...
Features
Assets
Blog
Help
Learn
Get App
Login
Sign Up
Get App
Regeneron Pharmaceuticals (REGN) Q1 2024 Earnings
REGN
2
Feb
Confirmed
Q2 2023
Q3 2023
Q4 2023
Q1 2024
9.61
10.36
11.11
11.86
Details
Expected EPS
10.77
Actual EPS
11.86
Surprise EPS
1.09
Surprise Percent
+10.12%
Description
Regeneron Pharmaceuticals (REGN) has reported earnings of 11.86 per share for Q1 2024.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login